Singh Ashish

7PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 29, 2026
A Comparative Analysis of Fertility-Sparing Surgery and Complete Staging Surgery in Early Stage Epithelial Ovarian Cancer: Impact on Oncological Outcomes.

|Mar 09, 2026
Cetuximab in platinum-ineligible patients with locally advanced squamous cell carcinoma of the head and neck: Consensus from India.

Agarwala Vivek, Aggarwal Shyam, Agrawal Shyam

|Mar 24, 2025
Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched Analysis.

Praveen Kumar Marimuthu, Josh Thomas Georgy, Deepa Susan Joy Philip

|Jun 21, 2024
Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting.

Heber Rew Bright, Ashish Singh, Anjana Joel

|Nov 03, 2023
Low-dose nivolumab and cabozantinib in recurrent intestinal-type papillary adenocarcinoma of the sinonasal region.

Zachariah Thomas, Prashant Jambunathan, Anjali Jibi

|Feb 16, 2023
Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India.

Dharna Gupta, Ashish Singh, Nidhi Gupta

Pageof 2

Frequent Collaborators

3 joint publications

Ajoy Oommen John

2 joint publications

Nidhi Gupta

2 joint publications

Manjunath Nookala Krishnamurthy

2 joint publications

Anjana Joel